Growth Metrics

Palisade Bio (PALI) Receivables - Net (2016 - 2023)

Palisade Bio (PALI) has disclosed Receivables - Net for 12 consecutive years, with $250000.0 as the latest value for Q1 2023.

  • On a quarterly basis, Receivables - Net changed N/A to $250000.0 in Q1 2023 year-over-year; TTM through Mar 2023 was $250000.0, a N/A change, with the full-year FY2020 number at $59000.0, up 180.1% from a year prior.
  • Receivables - Net was $250000.0 for Q1 2023 at Palisade Bio, up from $59000.0 in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $250000.0 in Q1 2023 to a low of $8779.0 in Q3 2020.
  • A 4-year average of $84354.1 and a median of $59000.0 in 2020 define the central range for Receivables - Net.
  • Peak YoY movement for Receivables - Net: tumbled 92.84% in 2019, then skyrocketed 248.33% in 2021.
  • Palisade Bio's Receivables - Net stood at $21064.0 in 2019, then skyrocketed by 180.1% to $59000.0 in 2020, then changed by 0.0% to $59000.0 in 2021, then surged by 323.73% to $250000.0 in 2023.
  • Per Business Quant, the three most recent readings for PALI's Receivables - Net are $250000.0 (Q1 2023), $59000.0 (Q2 2021), and $25259.0 (Q1 2021).